Key result
Prospective case-control study design outlines an investigation of microparticles in diabetic retinopathy progression.
Why the study?
The role of specific circulating microparticles as conveyors of bio-active molecules and modulators by miRNAs in diabetic retinopathy and metabolic syndrome is not fully understood.
What is the role of circulating microparticles and miRNAs in the pathomechanisms of diabetic retinopathy in patients with diabetes and metabolic syndrome?
Case-Control (n=120)
What is the role of circulating microparticles and miRNAs in the pathomechanisms of diabetic retinopathy in patients with diabetes and metabolic syndrome?
Answers are grounded in this paper and cite their sources.
This proposed study aims to elucidate the role of circulating microparticles and miRNAs in the development of diabetic retinopathy among patients with diabetes and metabolic syndrome.
The project is proposed to explain the role of specific circulating microparticles (MPs) as conveyors in trafficking bio-active molecules in type 1 (T1DM) and type 2 (T2DM) diabetic patients with risk of diabetic retinopathy (DR) and in patients with metabolic syndrome (MS). The possible role of miRNAs as modulators of these processes (in switching on/off mechanism on the molecular level) is proposed. An increased number of MPs with respect to glucose concentrations and levels of proangiogenic factors in vivo (patients’ plasma) is expected. The relationship between age of patents and MP content (cell membrane glycoproteins, phosphatidylserine or miRNA profile) is possible. MPs will be obtained from T1DM (n = 30) T2DM (n = 30), MS (n = 30) and controls (n = 30). Retinopathy in diabetic patients will be assessed by imaging method. Biological profile of MPs will be assessed in vitro by means of flow cytometry, molecular biology methods and cell proliferation assays.
No takes yet. Share an insight, caveat, or question.
Stępień et al. (2014) conducted a case-control in Diabetic retinopathy, Type 1 Diabetes, Type 2 Diabetes, Metabolic Syndrome (n=120). Circulating microparticles and miRNA profiles vs. Healthy controls was evaluated on Progression of diabetic retinopathy assessed by the area of choroidal neovascularization, submacular leakage, and hemorrhage. This paper presents the rationale and design of a prospective case-control study investigating the role of microparticles in diabetic retinopathy, with no clinical results reported yet.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: